{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:17:23Z","timestamp":1787001443959,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2001,12]]},"DOI":"10.1023\/a:1015259706522","type":"journal-article","created":{"date-parts":[[2002,12,28]],"date-time":"2002-12-28T17:49:38Z","timestamp":1041097778000},"page":"199-206","source":"Crossref","is-referenced-by-count":17,"title":["Enoxaparin in Unstable Angina\/Non-ST-Segment Elevation Myocardial Infarction: Treatment Benefits in Prespecified Subgroups"],"prefix":"10.1007","volume":"12","author":[{"given":"Marc","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliott Marshall","family":"Antman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique Pablo","family":"Gurfinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Radley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"397942_CR1","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1161\/01.CIR.90.4.2126","volume":"90","author":"V. Fuster","year":"1994","unstructured":"Fuster V. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation 1994;90:2126-2146.","journal-title":"Circulation"},{"key":"397942_CR2","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM198810273191701","volume":"319","author":"P Th\u00e9roux","year":"1988","unstructured":"Th\u00e9roux P, Ouimet H, McCans J, et al. Aspirin, heparin or both to treat acute unstable angina. N Engl J Med 1988;319:1105-1111.","journal-title":"N Engl J Med"},{"key":"397942_CR3","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0140-6736(90)92336-G","volume":"336","author":"The RISC Group.","year":"1990","unstructured":"The RISC Group. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet 1990;336:827-830.","journal-title":"Lancet"},{"key":"397942_CR4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1161\/01.CIR.89.1.81","volume":"89","author":"M Cohen","year":"1994","unstructured":"Cohen M, Adams PC, Parry G, et al. Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Circulation 1994;89:81-88.","journal-title":"Circulation"},{"key":"397942_CR5","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1056\/NEJM199708143370702","volume":"337","author":"M Cohen","year":"1997","unstructured":"Cohen M, Demers C, Gurfinkel EP, et al. for the Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. A comparison of low molecular weight heparin with unfractionated heparin for unstable coronary artery disease. N Engl J Med 1997;337:447-452.","journal-title":"N Engl J Med"},{"key":"397942_CR6","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1161\/01.CIR.100.15.1593","volume":"100","author":"EM Antman","year":"1999","unstructured":"Antman EM, McCabe CH, Gurfinkel EP, et al. for the TIMI 11B Investigators. Enoxaparin prevents death and cardiac ischemic events in unstable angina\/non-Q-wave myocardial infarction: Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. Circulation 1999;100:1593-1601.","journal-title":"Circulation"},{"key":"397942_CR7","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1161\/01.CIR.100.15.1602","volume":"100","author":"EM Antman","year":"1999","unstructured":"Antman EM, Cohen M, Radley D, et al. for the TIMI 11B and ESSENCE Investigators. Assessment of the treatment effect of enoxaparin for unstable angina\/non-Q-wave myocardial infarction. TIMI 11BESSENCE meta-analysis. Circulation 1999;100: 1602-1608.","journal-title":"Circulation"},{"key":"397942_CR8","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/0002-9149(86)90031-7","volume":"58","author":"JI Farhi","year":"1986","unstructured":"Farhi JI, Cohen M, Fuster V. The broad spectrum of unstable angina pectoris and its implications for future controlled trials. Am J Cardiol 1986;58:547-550.","journal-title":"Am J Cardiol"},{"key":"397942_CR9","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1001\/jama.273.2.136","volume":"273","author":"JE Calvin","year":"1995","unstructured":"Calvin JE, Klein LW, Van den Berg BJ, et al. Risk stratification in unstable angina. Prospective validation of the Braunwald classification. J Am Med Assoc 1995;273:136-141.","journal-title":"J Am Med Assoc"},{"key":"397942_CR10","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1053\/euhj.1998.1480","volume":"20","author":"PH Stone","year":"1999","unstructured":"Stone PH, Thompson B, Zaret BL, et al. for the TIMIIIIB Investigators. Factors associated with failure of medical therapy in patients with unstable angina and non-Q-wave myocardial infarction. Eur Heart J 1999;20:1084-1093.","journal-title":"Eur Heart J"},{"key":"397942_CR11","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1053\/hj.1999.v138.99081","volume":"138","author":"CW. Hamm","year":"1999","unstructured":"Hamm CW. Risk stratifying acute coronary syndromes: gradient of risk and benefit. Am Heart J 1999;138:S6-S11.","journal-title":"Am Heart J"},{"key":"397942_CR12","first-page":"962","volume":"139","author":"M Cohen","year":"2000","unstructured":"Cohen M, Stinnett SS, Weatherley B, et al. for the ESSENCE Study Group. Predictors of recurrent ischemic events and death in unstable coronary artery disease after treatment with combination antithrombotic therapy.AmHeart J 2000;139:962-970.","journal-title":"AmHeart J"},{"issue":"1","key":"397942_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0735-1097(97)00160-5","volume":"30","author":"CP Cannon","year":"1997","unstructured":"Cannon CP, McCabe CH, Stone PH, et al. for the TIMI III Registry ECG Ancillary Study Investigators. The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III Registry ECG Ancillary Study. Thrombolysis in Myocardial Ischemia. J Am Coll Cardiol 1997;30(1):133-140.","journal-title":"J Am Coll Cardiol"},{"key":"397942_CR14","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJM199408183310701","volume":"331","author":"G Liuzzo","year":"1994","unstructured":"Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-424.","journal-title":"N Engl J Med"},{"key":"397942_CR15","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1056\/NEJM199610313351802","volume":"335","author":"EM Antman","year":"1996","unstructured":"Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996;335:1342-1349.","journal-title":"N Engl J Med"},{"key":"397942_CR16","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1056\/NEJM199712043372302","volume":"337","author":"CW Hamm","year":"1997","unstructured":"Hamm CW, Goldmann BU, Heeschen C, Kreymann G, Berger J, Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med 1997;337:1648-1653.","journal-title":"N Engl J Med"},{"key":"397942_CR17","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1001\/jama.284.7.835","volume":"284","author":"EM Antman","year":"2000","unstructured":"Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina\/non-ST elevation MI: A method for prognostication and therapeutic decision making. J Am Med Assoc 2000;284:835-842.","journal-title":"J Am Med Assoc"},{"key":"397942_CR18","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S0735-1097(00)00808-1","volume":"36","author":"SG Goodman","year":"2000","unstructured":"Goodman SG, Cohen M, Bigonzi F, et al. Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE Study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q Wave Coronary Events. J Am Coll Cardiol 2000;36:693-698.","journal-title":"J Am Coll Cardiol"},{"key":"397942_CR19","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/01.CIR.93.5.870","volume":"93","author":"CB Granger","year":"1996","unstructured":"Granger CB, Hirsch J, Califf RM, et al. Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trial. Circulation 1996;93:870-878.","journal-title":"Circulation"},{"key":"397942_CR20","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000176905","volume":"86","author":"L Laslett","year":"1995","unstructured":"Laslett L, White R. Predictors of the effect of heparin during cardiac catheterization. Cardiology 1995;86: 380-383.","journal-title":"Cardiology"},{"key":"397942_CR21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/clpt.1981.53","volume":"29","author":"RJ Cipolle","year":"1981","unstructured":"Cipolle RJ, Siefert RD, Neilan BA, Zaske DE, Haus E. Heparin kinetics: variables related to disposition and dosage. Clin Pharmacol Ther 1981;29:387-393.","journal-title":"Clin Pharmacol Ther"},{"key":"397942_CR22","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0002-8703(99)70461-8","volume":"137","author":"H Toss","year":"1999","unstructured":"Toss H, Wallentin L, Siegbahn A. Influences of sex and smoking habits on anticoagulant activity in low-molecular-weight heparin treatment of unstable coronary artery disease. Am Heart J 1999;137:72-78.","journal-title":"Am Heart J"},{"key":"397942_CR23","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1023\/A:1008922527826","volume":"8","author":"EP Gurfinkel","year":"1999","unstructured":"Gurfinkel EP, Duronto E, Colorio C, Bozovich G, Cohen M, Mautner B, on behalf of the ESSENCE Study Group. Thrombotic reactant markers in non-Enoxaparin in UA=NSTEMI: Subgroup Analyses 205 ST segment elevation acute coronary syndromes treated with either enoxaparin (low molecular weight heparin) or unfractioned heparin. J Thromb Thrombolysis 1999;8:227-232.","journal-title":"J Thromb Thrombolysis"},{"issue":"1","key":"397942_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0735-1097(01)01308-0","volume":"38","author":"B Lagerqvist","year":"2001","unstructured":"Lagerqvist B, Safstrom K, Stahle E, Wallentin L, Swahn E. Is early invasive treatment of unstable coronary artery disease equally effective for both women and men? FRISC II Study Group Investigators. J Am Coll Cardiol 2001;38(1):41-48.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"397942_CR25","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/jama.284.7.835","volume":"284","author":"EM Antman","year":"2000","unstructured":"Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina\/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA 2000;284(7):835-842.","journal-title":"JAMA"},{"key":"397942_CR26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/01.CIR.96.1.61","volume":"96","author":"W Klein","year":"1997","unstructured":"Klein W, Buchwald A, Hillis SE, et al. for the FRIC Investigators. Comparison of low molecular weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Circulation 1997;96:61-68.","journal-title":"Circulation"},{"key":"397942_CR27","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1053\/euhj.1999.1879","volume":"20","author":"The FRAXIS Study Group.","year":"1999","unstructured":"The FRAXIS Study Group. Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAXIS. (FRAXiparine in Ischaemic Syndromes). Eur Heart J 1999;20:1553-1562.","journal-title":"Eur Heart J"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1015259706522.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1015259706522\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1015259706522.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T07:11:21Z","timestamp":1754637081000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1015259706522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["397942"],"URL":"https:\/\/doi.org\/10.1023\/a:1015259706522","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,12]]}}}